Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report
Kansu, E.; Koc, Y.; Kars, A.; Alakavuklar, M.; Tekuzman, G.; Firat, D.
Journal of ChemoTherapy 1(4 Suppl): 1268-1270
1989
ISSN/ISBN: 1120-009X PMID: 16312861 Document Number: 331726
Document emailed within 1 workday
Related Documents
Harakati, M.S. 1999: Cytosine arabinoside, mitoxantrone, and etoposide in the treatment of adult patients with previously untreated acute myeloid leukemia Saudi Medical Journal 20(4): 291-295Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Arlin, Z.; Case, D.C.; Moore, J.; Wiernik, P.; Feldman, E.; Saletan, S.; Desai, P.; Sia, L.; Cartwright, K. 1990: Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group Leukemia 4(3): 177-183
Wakita, A.; Murase, T.; Uchida, T.; Fujiwara, Y.; Tanaka, M.; Ohkita, T. 1992: Mitoxantrone and conventional-dose cytosine arabinoside for relapsed and refractory acute leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(5): 653-657
Sanz, M.A.; Martínez, J.; Borrego, D.; Martín-Aragonés, G.; Lorenzo, I.; Sanz, G.; Sayas, M.J.; Jarque, I.; Pastor, E.; Rafecas, J. 1987: High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1): 18-20
Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Hoelzer, D.; Thiel, E.; Löffler, H.; Büchner, T.; Ganser, A.; Heil, G.; Kurrle, E.; Heimpel, H.; Koch, P.; Lipp, T. 1987: Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1: 92-97
Burns, C.P. 1975: Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia Cancer ChemoTherapy Reports 59(4): 757-760
Taguchi, H.; Kubonishi, I.; Takehara, N.; Uemura, Y.; Iwahara, Y.; Eguchi, T.; Miyagi, T.; Sugito, S.; Muneishi, H.; Tanaka, Y. 1992: Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(9): 1309-1314
Huang, M.E.; Ye, Y.C.; Zhao, L. 1987: Treatment of acute promyelocytic leukemia by retinoic acid with or without low dose cytosine arabinoside: report of 4 cases Zhonghua Nei Ke Za Zhi 26(6): 330
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Lin, S.F.; Liu, H.W.; Chen, T.P. 1990: Chemotherapy for acute non-lymphocytic leukemia with low-dose cytosine arabinoside (Ara-C) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 53(1): 45-50
Hirschmann, W.D.; Kovacs, E.L.; Gerecke, D.; Kaulen, H.D.; Voigtmann, R.; Gross, R. 1975: Method of administration and inactivation of cytosine arabinoside in acute leukemia Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1114-1116
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262
Wysocki, M.; Nowaczyk-Michalak, A.; Pilecki, O.; Trybuś, L.; Balcar-Boroń, A. 1992: Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia Acta Haematologica Polonica 23(3): 197-199
Ramsay, N.K.; Coccia, P.F.; Krivit, W.; Bloomfield, C.D.; Nesbit, M.E. 1976: Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia Cancer Treatment Reports 60(11): 1683-1685
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109